SightfileU.S. market data from official filings

PALISADE BIO INC (PALI)

Name: PALISADE BIO INC (PALI) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001357459 · EDGAR filings · Updated 2026-07-10

PALISADE BIO INC (PALI) has reported institutional ownership of 88.4%, with 96 institutional managers holding positions valued at $256.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

88.4%

Institutional managers

Reported 13F value

$256.8M

Insider activity

6 trans.

$7.45K net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-10 — Insider transaction reported (Form 4)
2026-07-08 — Insider transaction reported (Form 4)
2026-07-08 — Insider transaction reported (Form 4)
2026-07-08 — Insider transaction reported (Form 4)
2026-07-07 — Notice of proposed sale filed (Form 144)
2026-07-07 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PALISADE BIO INC has 96 institutional holders and institutional ownership of 88.4%.

Insider activity

Insiders reported 6 transactions (2 buys, 2 sells) across 3 reporting insiders, with a net reported value of $7.45K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-20 (recurring since 2020-03-27) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-05-02 (recurring since 2020-04-02) — source filing. The authoritative details are those stated in the filing itself.

Related companies

REZOLUTE INC (RZLT) · ORTHOPEDIATRICS CORP (KIDS) · SURROZEN INC (SRZN) · EIKON THERAPEUTICS INC (EIKN) · Immix Biopharma Inc (IMMX) · AGOMAB THERAPEUTICS NV (AGMB)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.